Corporate News
Evaxion Biotech A‑S (EVAX) closed the trading session on Thursday, 22 November 2026, down 8.4 % at 11:48 PM Central European Time. The closing price was USD 3.71 per share.
- Shares outstanding: 9 million
- Market capitalization: USD 33.5 million
- Volume traded in the last 24 hours: approximately USD 1.2 million
- Year‑to‑date performance: 13.46 % increase since the end of the previous month
- 200‑day simple moving average: USD 3.57
- 52‑week range: high of USD 6.92 on 12 September 2025; low of USD 2.72 on 13 October 2026
Comparative performance of related stocks
| Symbol | Exchange | 24‑hour change | Current price | Market cap | Additional metric |
|---|---|---|---|---|---|
| Hove A‑S (HOVE.CO) | Copenhagen | +0.58 % | DKK 6.78 | DKK 173.4 million | P/E = 8.18 |
| Impero A‑S (905.F) | Frankfurt | –1.12 % | EUR 0.82 | EUR 23.3 million | – |
| 5th Planet Games A‑S (5PG.OL) | Oslo | –1.87 % | NOK 1 | NOK 266.7 million | – |
| Strategic Investments A‑S (STRINV.CO) | Copenhagen | +0.36 % | DKK 0.57 | DKK 234.8 million | P/E = 4.21 |
| German High Property (GERHSP.CO) | Copenhagen | 0 % | DKK 64.5 | DKK 235.7 million | – |
Company overview
Evaxion Biotech A‑S is a Danish biotechnology firm listed on the Nasdaq stock exchange. The company focuses on the development and commercialization of vaccines and other therapeutic products.
